154 related articles for article (PubMed ID: 19654499)
21. Cervical cancer in patients infected with the human immunodeficiency virus.
Leitao MM; White P; Cracchiolo B
Cancer; 2008 Jun; 112(12):2683-9. PubMed ID: 18438877
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for severe disease in adults with falciparum malaria.
Phillips A; Bassett P; Zeki S; Newman S; Pasvol G
Clin Infect Dis; 2009 Apr; 48(7):871-8. PubMed ID: 19243243
[TBL] [Abstract][Full Text] [Related]
23. Mantoux reaction in patients with HIV-related pulmonary tuberculosis in Maiduguri, Nigeria.
Yusuph H; Garbati MA; Gashau W
Afr J Med Med Sci; 2005 Jun; 34(2):125-8. PubMed ID: 16749335
[TBL] [Abstract][Full Text] [Related]
24. Incidence and risk factors of nevirapine-associated severe hepatitis among HIV-infected patients with CD4 cell counts less than 250 cells/microL.
Manosuthi W; Sungkanuparph S; Tansuphaswadikul S; Chottanapund S; Mankatitham W; Chimsuntorn S; Sittibusaya C; Moolasart V; Chaovavanich A
J Med Assoc Thai; 2008 Feb; 91(2):159-65. PubMed ID: 18389979
[TBL] [Abstract][Full Text] [Related]
25. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
[TBL] [Abstract][Full Text] [Related]
26. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts.
Teck R; Ascurra O; Gomani P; Manzi M; Pasulani O; Kusamale J; Salaniponi FM; Humblet P; Nunn P; Scano F; Harries AD; Zachariah R
Int J Tuberc Lung Dis; 2005 Mar; 9(3):258-62. PubMed ID: 15786887
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: a EuroSIDA study.
Podlekareva D; Mocroft A; Dragsted UB; Ledergerber B; Beniowski M; Lazzarin A; Weber J; Clumeck N; Vetter N; Phillips A; Lundgren JD;
J Infect Dis; 2006 Sep; 194(5):633-41. PubMed ID: 16897662
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of malaria parasitaemia in adult HIV-infected patients in Jos, North-central Nigeria.
Iroezindu MO; Agaba EI; Okeke EN; Daniyam CA; Obaseki DO; Isa SE; Idoko JA
Niger J Med; 2012; 21(2):209-13. PubMed ID: 23311193
[TBL] [Abstract][Full Text] [Related]
29. The impact of cirrhosis on CD4+ T cell counts in HIV-seronegative patients.
McGovern BH; Golan Y; Lopez M; Pratt D; Lawton A; Moore G; Epstein M; Knox TA
Clin Infect Dis; 2007 Feb; 44(3):431-7. PubMed ID: 17205454
[TBL] [Abstract][Full Text] [Related]
30. Possible biochemical impact of malaria infection in subjects with HIV co-infection in Anambra state, Nigeria.
Onyenekwe CC; Ukibe N; Meludu SC; Ifeanyi M; Ezeani M; Onochie A; Ofiaeli N; Aboh N; Ilika A
J Vector Borne Dis; 2008 Jun; 45(2):151-6. PubMed ID: 18592844
[TBL] [Abstract][Full Text] [Related]
31. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
[TBL] [Abstract][Full Text] [Related]
32. Incidence and risk factors of nevirapine-associated skin rashes among HIV-infected patients with CD4 cell counts <250 cells/microL.
Manosuthi W; Sungkanuparph S; Tansuphaswadikul S; Inthong Y; Prasithsirikul W; Chottanapund S; Mankatitham W; Chimsuntorn S; Sittibusaya C; Moolasart V; Chumpathat N; Termvises P; Chaovavanich A
Int J STD AIDS; 2007 Nov; 18(11):782-6. PubMed ID: 18005514
[TBL] [Abstract][Full Text] [Related]
33. Bacterial pneumonia in HIV-infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome.
Curran A; Falcó V; Crespo M; Martinez X; Ribera E; Villar del Saz S; Imaz A; Coma E; Ferrer A; Pahissa A
HIV Med; 2008 Oct; 9(8):609-15. PubMed ID: 18557951
[TBL] [Abstract][Full Text] [Related]
34. HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.
Shah SN; Smith EE; Obonyo CO; Kain KC; Bloland PB; Slutsker L; Hamel MJ
J Infect Dis; 2006 Dec; 194(11):1519-28. PubMed ID: 17083036
[TBL] [Abstract][Full Text] [Related]
35. Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.
Sirikwin S; Likanonsakul S; Waradejwinyoo S; Pattamadilok S; Kumperasart S; Chaovavanich A; Manatsathit S; Malerczyk C; Wasi C
Vaccine; 2009 Jul; 27(32):4350-4. PubMed ID: 19487057
[TBL] [Abstract][Full Text] [Related]
36. Hospitalization criteria in imported falciparum malaria.
Briand V; Bouchaud O; Tourret J; Behr C; Abgrall S; Ralaimazava P; Le Bras J; Fontanet A
J Travel Med; 2007; 14(5):306-11. PubMed ID: 17883461
[TBL] [Abstract][Full Text] [Related]
37. The role of serum cryptococcal antigen screening for the early diagnosis of cryptococcosis in HIV-infected patients with different ranges of CD4 cell counts.
Pongsai P; Atamasirikul K; Sungkanuparph S
J Infect; 2010 Jun; 60(6):474-7. PubMed ID: 20347868
[TBL] [Abstract][Full Text] [Related]
38. [Immunologic findings in HIV infected children with bacterial infections].
Bunikowski R; Mielke M; Langhof M; Skarabis H; Schmitt M; Grosch-Wörner I
Klin Padiatr; 1996; 208(5):304-9. PubMed ID: 8992099
[TBL] [Abstract][Full Text] [Related]
39. Enhanced T cell activation in Plasmodium falciparum malaria-infected human immunodeficiency virus-1 patients from Mozambique.
Chavale H; Santos-Oliveira JR; Da-Cruz AM; Enosse S
Mem Inst Oswaldo Cruz; 2012 Dec; 107(8):985-92. PubMed ID: 23295747
[TBL] [Abstract][Full Text] [Related]
40. Plasmodium falciparum infection in HIV-infected patients on highly active antiretroviral therapy (HAART) in Benin City, Nigeria.
Akinbo FO; Omoregie R
J Res Health Sci; 2012; 12(1):15-8. PubMed ID: 22888709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
